MEET NINA
Your Noninvasive
Neuromodulation Assistant
For patients who don’t want to take another pill and aren’t ready for surgery, NiNA* may be an ideal alternative to medication. NiNA uses proprietary technologies to optimally target and activate the saphenous while maintaining user comfort. This simple, discreet system for the treatment of OAB requires just 30 minutes of stimulation and is designed to deliver significant, durable symptom reduction all done in the convenience of your own home.
Drug-Free, Noninvasive, At-Home Therapy For OAB
85%
patients prefer NiNA to medications 3 to 1²
3 to 1
Physicians would prescribe NiNA to 85% of their OAB patients¹
Initial nSAFN clinical experience demonstrates efficacy on-par with published results for medications and other competing therapies.
Noninvasive Saphenous Neuromodulation (nSAFN) has been studied in 3 feasibility studies to date at 7 centers in the US and Canada.³
UUI reduction in UUI
responders³
78%
OAB responders³˒⁴
65%
85%
28%
UUI responders³
of patients were Dry³
Competive
Therapies
NINA
Medications
Percutaneous Tibial Neuromodulation (PTNS)
NO serious adverse effects
Significant side-effects
Weekly office visits
Done at home
Sacral Neuromodulation (SNS)
Surgery required
Completely noninvasive
Botulinum Toxin
Completely noninvasive, done at home
Bladder wall injections
THE FUTURE OF NINA
Not only does NiNA offer revolutionary at-home neuromodulation therapy, but the introduction of the NiNA CareTM app 6 will also add comprehensive educational content developed by world-renowned physicians– maximizing patient engagement and the potential for successful, durable outcomes.
An Intelligent Companion App and Ecosystem
¹9,610,442. 9,884,187
²Moazzam, Z. & Yoo, P. (2018). Frequency-dependent inhibition of bladder function by saphenous nerve stimulation in anesthetized rats. Neurourology and urodynamics, 37(2), 592–599.
³Feasibility clinical outcomes, data on file.